Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 71104 | 2.82 |
09:34 ET | 8004 | 2.85 |
09:36 ET | 47732 | 2.825 |
09:38 ET | 1370 | 2.83 |
09:39 ET | 1300 | 2.839 |
09:41 ET | 4900 | 2.835 |
09:43 ET | 9318 | 2.825 |
09:45 ET | 8498 | 2.821 |
09:48 ET | 10297 | 2.825 |
09:50 ET | 8620 | 2.825 |
09:52 ET | 4937 | 2.825 |
09:54 ET | 52632 | 2.79 |
09:56 ET | 37987 | 2.77 |
09:57 ET | 14793 | 2.77 |
09:59 ET | 3605 | 2.77 |
10:01 ET | 2347 | 2.77 |
10:03 ET | 11848 | 2.77 |
10:06 ET | 15122 | 2.77 |
10:08 ET | 34273 | 2.77 |
10:10 ET | 200 | 2.775 |
10:12 ET | 3656 | 2.785 |
10:14 ET | 2675 | 2.775 |
10:15 ET | 3040 | 2.775 |
10:17 ET | 2557 | 2.765 |
10:19 ET | 3965 | 2.765 |
10:21 ET | 10380 | 2.75 |
10:24 ET | 2321 | 2.75 |
10:26 ET | 6492 | 2.75 |
10:28 ET | 3995 | 2.755 |
10:30 ET | 1236 | 2.755 |
10:32 ET | 7113 | 2.745 |
10:33 ET | 1666 | 2.746 |
10:35 ET | 15854 | 2.745 |
10:37 ET | 20988 | 2.75 |
10:39 ET | 3890 | 2.7499 |
10:42 ET | 4677 | 2.76 |
10:44 ET | 13573 | 2.745 |
10:46 ET | 447 | 2.745 |
10:48 ET | 148 | 2.745 |
10:50 ET | 2000 | 2.74 |
10:51 ET | 5772 | 2.735 |
10:53 ET | 2471 | 2.735 |
10:55 ET | 1717 | 2.735 |
10:57 ET | 3952 | 2.735 |
11:00 ET | 1400 | 2.7397 |
11:02 ET | 2500 | 2.73 |
11:04 ET | 6194 | 2.74 |
11:06 ET | 4737 | 2.7475 |
11:08 ET | 100 | 2.745 |
11:09 ET | 2800 | 2.735 |
11:11 ET | 1227 | 2.73 |
11:13 ET | 2356 | 2.73 |
11:15 ET | 899 | 2.73 |
11:18 ET | 1940 | 2.74 |
11:20 ET | 100 | 2.75 |
11:22 ET | 5058 | 2.745 |
11:24 ET | 5133 | 2.755 |
11:26 ET | 1373 | 2.74 |
11:27 ET | 218 | 2.74 |
11:29 ET | 507 | 2.74 |
11:31 ET | 6027 | 2.74 |
11:33 ET | 247 | 2.74 |
11:40 ET | 5314 | 2.73 |
11:42 ET | 100 | 2.735 |
11:44 ET | 7676 | 2.735 |
11:45 ET | 200 | 2.73 |
11:47 ET | 2997 | 2.72 |
11:49 ET | 308 | 2.72 |
11:51 ET | 1808 | 2.71 |
11:54 ET | 478 | 2.71 |
11:56 ET | 8308 | 2.7 |
11:58 ET | 3400 | 2.705 |
12:00 ET | 3208 | 2.715 |
12:02 ET | 1461 | 2.715 |
12:03 ET | 1300 | 2.72 |
12:05 ET | 1106 | 2.715 |
12:09 ET | 100 | 2.7199 |
12:12 ET | 2400 | 2.72 |
12:16 ET | 1955 | 2.715 |
12:18 ET | 300 | 2.7101 |
12:20 ET | 225 | 2.715 |
12:21 ET | 2967 | 2.715 |
12:23 ET | 1486 | 2.725 |
12:27 ET | 4968 | 2.73 |
12:30 ET | 4932 | 2.725 |
12:32 ET | 542 | 2.73 |
12:34 ET | 100 | 2.725 |
12:38 ET | 13889 | 2.72 |
12:39 ET | 200 | 2.715 |
12:41 ET | 438 | 2.715 |
12:43 ET | 5296 | 2.715 |
12:48 ET | 100 | 2.7175 |
12:50 ET | 14113 | 2.7 |
12:54 ET | 1300 | 2.7075 |
12:56 ET | 8705 | 2.695 |
12:57 ET | 6920 | 2.695 |
01:01 ET | 2400 | 2.695 |
01:03 ET | 100 | 2.695 |
01:06 ET | 1824 | 2.695 |
01:08 ET | 500 | 2.695 |
01:10 ET | 3296 | 2.695 |
01:12 ET | 9411 | 2.72 |
01:14 ET | 900 | 2.715 |
01:15 ET | 821 | 2.715 |
01:17 ET | 300 | 2.72 |
01:19 ET | 400 | 2.715 |
01:21 ET | 1000 | 2.72 |
01:24 ET | 600 | 2.72 |
01:26 ET | 895 | 2.715 |
01:28 ET | 345 | 2.72 |
01:30 ET | 300 | 2.715 |
01:32 ET | 2100 | 2.715 |
01:33 ET | 5052 | 2.705 |
01:35 ET | 3042 | 2.71 |
01:37 ET | 7750 | 2.72 |
01:39 ET | 4300 | 2.725 |
01:44 ET | 100 | 2.73 |
01:46 ET | 300 | 2.72 |
01:48 ET | 600 | 2.725 |
01:50 ET | 2577 | 2.71 |
01:55 ET | 200 | 2.715 |
01:57 ET | 3690 | 2.715 |
02:00 ET | 100 | 2.71 |
02:02 ET | 7230 | 2.715 |
02:04 ET | 10277 | 2.725 |
02:06 ET | 300 | 2.725 |
02:08 ET | 800 | 2.72 |
02:09 ET | 100 | 2.725 |
02:11 ET | 100 | 2.73 |
02:15 ET | 200 | 2.72 |
02:20 ET | 200 | 2.72 |
02:22 ET | 100 | 2.725 |
02:24 ET | 200 | 2.72 |
02:27 ET | 400 | 2.725 |
02:29 ET | 100 | 2.7201 |
02:31 ET | 15803 | 2.735 |
02:33 ET | 1773 | 2.735 |
02:36 ET | 1093 | 2.735 |
02:40 ET | 500 | 2.735 |
02:42 ET | 100 | 2.735 |
02:44 ET | 5071 | 2.735 |
02:45 ET | 18504 | 2.75 |
02:47 ET | 600 | 2.76 |
02:49 ET | 400 | 2.75 |
02:51 ET | 200 | 2.755 |
02:54 ET | 3853 | 2.755 |
02:56 ET | 2200 | 2.76 |
02:58 ET | 200 | 2.76 |
03:00 ET | 12443 | 2.76 |
03:02 ET | 3600 | 2.75 |
03:03 ET | 4156 | 2.76 |
03:05 ET | 7025 | 2.785 |
03:07 ET | 1700 | 2.785 |
03:09 ET | 14225 | 2.77 |
03:12 ET | 2251 | 2.775 |
03:14 ET | 1125 | 2.77 |
03:16 ET | 2001 | 2.7701 |
03:18 ET | 14012 | 2.785 |
03:20 ET | 500 | 2.785 |
03:21 ET | 19835 | 2.785 |
03:23 ET | 1500 | 2.785 |
03:25 ET | 100 | 2.785 |
03:27 ET | 1900 | 2.785 |
03:30 ET | 300 | 2.785 |
03:32 ET | 200 | 2.78 |
03:34 ET | 1516 | 2.785 |
03:36 ET | 1200 | 2.785 |
03:38 ET | 300 | 2.78 |
03:39 ET | 700 | 2.785 |
03:41 ET | 4035 | 2.775 |
03:43 ET | 200 | 2.775 |
03:45 ET | 2954 | 2.765 |
03:48 ET | 1000 | 2.765 |
03:50 ET | 429 | 2.765 |
03:52 ET | 18931 | 2.785 |
03:54 ET | 2745 | 2.785 |
03:56 ET | 20258 | 2.77 |
03:57 ET | 3384 | 2.775 |
03:59 ET | 206141 | 2.8 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 697.9M | -1.3x | --- |
Replimune Group Inc | 701.7M | -3.1x | --- |
ProKidney Corp | 692.3M | -3.7x | --- |
Oric Pharmaceuticals Inc | 692.0M | -5.2x | --- |
Olema Pharmaceuticals Inc | 710.1M | -5.6x | --- |
Lexicon Pharmaceuticals Inc | 690.5M | -2.4x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $697.9M |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 249.2M |
Nuvation Bio Inc does not pay a dividend. | |
Beta | 1.38 |
EPS | $-2.11 |
Book Value | $2.76 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 486.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,474.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.